Market Alert: Global Markets May Rebound Amid Signs of U.S. Economic Resilience

AML3D Secures AU$4.5 million Order from Major U.S. Shipbuilder

Oct 20, 2025

AML3D Limited (ASX: AL3) has secured an impressive contract valued at around AU$4.5 million from Newport News Shipbuilding (NNS) — a division of HII, recognized as the largest military shipbuilder in the United States. The order includes two custom ARCEMY® systems designed for heavy-capacity shipbuilding applications, marking the ninth and tenth systems supporting the U.S. Navy’s Maritime Industrial Base. These advanced 3D metal printing systems utilize AML3D’s patented Wire Additive Manufacturing (WAM®) process, known for reducing lead times, waste, and environmental impact while maintaining high-quality standards. Commissioning and deployment are planned for completion during Q2 2026. This contract strengthens AML3D’s position in the U.S. defense sector and aligns with its strategy to expand into non-defense industries and international markets, including the UK and Europe. The company continues leveraging its U.S. manufacturing base to support evolving government initiatives and tariff policies

 

 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com